Funder
ILDONG Pharmaceutical Co., Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science
Reference63 articles.
1. Abdoh A, Al-Omari M, Badwan A, Jaber A (2004) Amlodipine besylate–excipients interaction in solid dosage form. Pharm Dev TecHnol 9:15–24
2. Akinleye MO, Oyetunde OO, Okpara HE, Ayerota E (2012) Equivalence of two generic brands of amlodipine besylate under biowaiver conditions. Int J Pharm Pharm Sci 4:265–268
3. Alshora DH, Haq N, Alanazi FK, Ibrahim MA, Shakeel F (2016) Solubility of rosuvastatin calcium in different neat solvents at different temperatures. J Chem Thermodyn 94:230–233
4. Arshad MS, Zafar S, Yousef B, Alyassin Y, Ali R, Alasiri A, Chang M-W, Ahmad Z, Elkordy AA, Faheem A (2021) A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing. Adv Drug Deliv Rev 178:113840
5. Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E, Investigators ES (2007) Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study). Am J Cardiol 99:673–680